Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
PLpro
100%
Mpro
100%
Protease Assay
100%
Active Sites
60%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
40%
Rapid Screening
20%
Virus
20%
Substrate Binding
20%
Effective Screening
20%
Antiviral Activity
20%
Inhibition Mechanism
20%
Biochemical Activity
20%
Protease
20%
X-ray Crystal Structure
20%
Efficient Development
20%
Protease Inhibitors
20%
Screening Strategy
20%
Covalent Bond Formation
20%
Rapid Identification
20%
Promising Target
20%
Polyprotein Processing
20%
Dual Inhibition
20%
Structural Determination
20%
Low Cytotoxicity
20%
Sitagliptin
20%
Drug Repurposing
20%
Antiviral Screening
20%
In Silico Docking
20%
Antiviral Drug Development
20%
Delta Variant
20%
SARS-CoV-2 Main Protease
20%
Daclatasvir
20%
Anti-SARS-CoV-2 Activity
20%
Lycorine
20%
Nelfinavir Mesylate
20%
Activity Assessment
20%
Pharmacology, Toxicology and Pharmaceutical Science
Proteinase
100%
SARS Coronavirus
100%
Antivirus Agent
50%
Drug Development
16%
Proteinase Inhibitor
16%
Polyprotein
16%
Covalent Bond
16%
Nelfinavir
16%
Antiviral Drug
16%
Sitagliptin
16%
Cytotoxicity
16%
Delta Variant
16%
Virus
16%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Protease
100%
Active Site
50%
Crystal Structure
16%
X Ray
16%
Protease
16%
Protease Inhibitor
16%
Cytotoxicity
16%
Mesylate
16%
Nelfinavir
16%
Covalent Bond
16%
Drug Development
16%
Virus
16%
Immunology and Microbiology